Osiris Therapeutics (OSIR) researches, develops, manufactures, markets, and distributes regenerative medicine products.
OSIR products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chronic wounds, venous leg ulcers, and burns; BIO4, a bone allograft for use in all surgical applications, including spine, trauma, extremity, cranial, and foot and ankle surgery; and Cartiform, a viable chondral allograft that promotes articular cartilage repair to treat focal chondral defects.
Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.
- December 8, 2015 - 8:57am | Research Notes
- November 4, 2015 - 8:33am | Research Notes
- November 2, 2015 - 9:02am | Research Notes
- October 6, 2015 - 10:37am | Research Notes, Regulatory
- September 21, 2015 - 11:39am | BOD & C-Suite Updates
- July 26, 2015 - 11:46am | Research Notes
- July 18, 2015 - 3:33pm | Research Notes
- July 14, 2015 - 7:59pm | Earnings Alert
- July 12, 2015 - 5:53pm | Research Notes
- July 5, 2015 - 3:07pm | Research Notes
- April 21, 2015 - 9:07am | BOD & C-Suite Updates
- April 9, 2015 - 9:32am | BOD & C-Suite Updates
- February 11, 2015 - 9:00am | Earnings Alert
- December 23, 2014 - 8:21am | Research Notes
- December 8, 2014 - 10:58am | Financings
- December 3, 2014 - 9:25am | BOD & C-Suite Updates
- November 26, 2014 - 9:24am | BOD & C-Suite Updates
- November 14, 2014 - 1:58pm | Earnings
- November 7, 2014 - 12:32pm | Earnings
- October 17, 2014 - 9:13am | News